Systemic therapies for joint disease in horses.
Systemic therapies for joint disease may be prescribed when a single joint is involved or when multiple sites are affected. The precise therapeutic regimen recommended depends on the duration,cause, and site(s) of injury and is often an adjunct to intra-articular or supportive therapies. If the clinical signs of joint disease are acute and moderate in severity, nonsteroidal anti-inflammatory drugs are often administered to alleviate pain and inflammation. When aiming for more of a generalized maintenance or chondro-protective regimen, an alternative medication, such as hyaluronan,polysulfated glycosaminoglycan, or a nutraceutical will commonly be prescribed.
Fortier
Lisa A
LA
Department of Clinical Sciences, Veterinary Medical College, VMC C3-181, Cornell University, Ithaca, NY 14853, USA. laf4@cornell.edu
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D003131:Combined Modality Therapy / Q000379:methods / Q000662:veterinary; D006025:Glycosaminoglycans / Q000627:therapeutic use; D006734:Horse Diseases / Q000188:drug therapy / Q000628:therapy*; D006736:Horses; D006820:Hyaluronic Acid / Q000627:therapeutic use; D007592:Joint Diseases / Q000188:drug therapy / Q000628:therapy / Q000662:veterinary*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D006025:Glycosaminoglycans; D006820:Hyaluronic Acid